A vaccine-induced public antibody protects against SARS-CoV-2 and emerging variants
Aaron J. Schmitz, Jackson S. Turner, Zhuoming Liu, Julian Q. Zhou, Ishmael D. Aziati, Rita E. Chen, Astha Joshi, Traci L. Bricker, Tamarand L. Darling, Daniel C. Adelsberg, Clara G. Altomare, Wafaa B. Alsoussi, James Brett Case, Laura A. VanBlargan, Tingting Lei, Mahima Thapa, Fatima Amanat, Trushar Jeevan, Thomas Fabrizio, Jane A. O’Halloran, Pei‐Yong Shi, Rachel M. Presti, Richard J. Webby, Florian Krammer, Sean P. J. Whelan, Goran Bajic, Michael Diamond, Adrianus C. M. Boon, Ali H. Ellebedy
Topics & Concepts
VirologyBiologyMonoclonal antibodyNeutralizationAntibodyVaccinationAntigenGerminal centerImmunologyB cellSARS-CoV-2 and COVID-19 ResearchViral gastroenteritis research and epidemiologyCOVID-19 Clinical Research Studies